Karthasis Radar · Zimbabwe
MCAZ introduces service charter for registration and licensing

Zimbabwe’s Medicines Control Authority has launched a client charter setting service standards and timelines for medicine registration, licensing and other operations.
What happened
The Medicines Control Authority of Zimbabwe has launched a Client Service Charter covering service standards and timelines, including medicine registration and licensing. The Herald reported the announcement on 19 October.
MCAZ communications manager Davidson Kaiyo linked the initiative to fair treatment, transparency and timely access to safe, effective, quality medicines. The announcement sets out the regulator’s service commitments; it is not a report of measured improvements in processing performance.
Why it matters
Predictability matters when organisations coordinate regulatory submissions with production, distribution and commercial activity. A service charter gives stakeholders a common reference for understanding expectations and organising their interactions with an authority.
Clear commitments can also support more useful communication about the progress of an application. Their practical value will depend on how they are applied and how stakeholders use the published requirements.
Commercial perspective
Manufacturers, importers and distributors can review the charter alongside their submission workflows. Planning should use the applicable published requirements and allow for the particulars of each application. Over time, actual service performance will be more informative than the launch announcement alone. Companies considering market entry should distinguish a stated service standard from a guaranteed outcome for an individual product.
The Karthasis newsletter
Stay ahead of the pharma market.
Pharmaceutical market news and insights from Zimbabwe and South Africa, delivered your way.
www.karthasis.com · Pharmaceutical intelligence